Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Detection of Actionable Alterations in Breast and Ovarian Tumor Tissues by a 50-Gene NGS Panel Testing

AMP2020: Association for Molecular Pathology Annual Meeting & Expo  
Virtual [in-person conference canceled], November 19-21, 2020

Detection of actionable alterations in breast and ovarian tumor tissues by a 50-gene NGS panel testing

Authors: Rosenthal SH, Ma C, Acab A, Grupe A, Van Ness M, Sugganth D, Racke F, Lacbawan F

Specialties: oncology, genetics

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.